Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial, page-27

half full - as i said time will tell. I hope you're right but most of those comments sound straight from the RSH marketing department. At least someone is marketing the product i suppose.

"major win" sigh. Agree current monitoring is suboptimal and there's a big gap in how it is now and how it should be, doesn't mean wheezo has a place in that future, and the way i read it this study will deduce that. Major win will be a positive result from the trial not the fact the trial is taking place.

I'll keep your comments above handy so we can assess but If i did that for the last 5 years it would make embarrassing reading for alot of posters here. Perhaps a more balanced outlook would benefit the general discussions.